Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461225 · ClinicalTrials.gov registry record · NA
Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain
A NA study, sponsored by Erchonia Corporation.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02461225 is a NA study that has completed, run by Erchonia Corporation. The registered enrollment target is 30 participants.
The verdict
NCT02461225, a NA study, has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether low level laser therapy is effective in the reduction of foot pain associated with diabetic peripheral neuropathy.
Interventions
- DEVICE Placebo Laser
- DEVICE Erchonia® FX-635™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02461225
The ClinicalTrials.gov registry entry for NCT02461225 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Erchonia Corporation, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Laser is the first listed.
NCT02461225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02461225 about?
NCT02461225 is a clinical study titled "Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain". The purpose of this study is to determine whether low level laser therapy is effective in the reduction of foot pain associated with diabetic peripheral neuropathy.
What is the current status of trial NCT02461225?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-03-01. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT02461225?
The interventions under investigation include: Placebo Laser (DEVICE), Erchonia® FX-635™ (DEVICE).
Who is sponsoring clinical trial NCT02461225?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.